What's not to like. Everything is going to plan and money in the bank. For those wanting to increase their position I wouldn't leave it too late.
it will be lovely to watch the SP go up over coming months.
- Botanix is on track to launch its patient experience program in Q3 CY2024, resulting in firstprescriptions for Sofdra in early Q4 CY2024
- Cash position of $79.31 million at June 2024 quarter end with no debt
What's not to like. Everything is going to plan and money in the...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.5¢ |
Change
-0.010(2.67%) |
Mkt cap ! $660.6M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 38.0¢ | 36.0¢ | $538.7K | 1.467M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 211932 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 215354 | 4 |
View Market Depth
| Last trade - 10.42am 31/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |